A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation

NCT00723606 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

376

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Intramuscular ziprasidone mesylate
DRUG: Intramuscular haloperidol

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.